A novel class of Plasmodial ClpP protease inhibitors as potential antimalarial agents.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2017-10-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2017.08.049PMID 28917450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting Protein Translation in Organelles of the Apicomplexa.

  2016cited by this paper
• Targeting apicoplasts in malaria parasites

  2013cited by this paper
• Structural Insights into the Inactive Subunit of the Apicoplast-localized Caseinolytic Protease Complex of Plasmodium falciparum*

  2012cited by this paper
• A Research Agenda to Underpin Malaria Eradication

  2011cited by this paper
• Identifying apicoplast‐targeting antimalarials using high‐throughput compatible approaches

  2011cited by this paper
• A Research Agenda for Malaria Eradication: Drugs

  2011cited by this paper
• Adult and child malaria mortality in India: a nationally representative mortality survey.

  2010cited by this paper
• Antibiotics in malaria therapy and their effect on the parasite apicoplast.

  2010cited by this paper
• A cyanobacterial serine protease of Plasmodium falciparum is targeted to the apicoplast and plays an important role in its growth and development

  2010cited by this paper
• Artemisinin resistance in Plasmodium falciparum malaria.

  2009cited by this paper
• Targeting the transcriptional and translational machinery of the endosymbiotic organelle in apicomplexans.

  2008cited by this paper
• Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics.

  2008cited by this paper
• Multiple Antibiotics Exert Delayed Effects against the Plasmodium falciparum Apicoplast

  2007cited by this paper
• Telithromycin and Quinupristin-Dalfopristin Induce Delayed Death in Plasmodium falciparum

  2007cited by this paper
• Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms.

  2007cited by this paper
• The effects of anti-bacterials on the malaria parasite Plasmodium falciparum.

  2007cited by this paper
• Crystal structure at 1.9A of E. coli ClpP with a peptide covalently bound at the active site.

  2006cited by this paper
• The apicoplast of Plasmodium falciparum is translationally active

  2005cited by this paper
• Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin–proteasome system and onto human diseases and drug targeting*

  2005cited by this paper
• Simple and Inexpensive Fluorescence-Based Technique for High-Throughput Antimalarial Drug Screening

  2004cited by this paper
• Tropical infectious diseases: Metabolic maps and functions of the Plasmodium falciparum apicoplast

  2004cited by this paper
• Inhibition of mitochondrial and plastid activity of Plasmodium falciparum by minocycline

  2002cited by this paper
• Hydrolysis of erythrocyte proteins by proteases of malaria parasites

  2002cited by this paper
• The plastid DNA of the malaria parasite Plasmodium falciparum is replicated by two mechanisms

  2002cited by this paper
• Protein trafficking to the plastid of Plasmodium falciparum is via the secretory pathway

  2000cited by this paper
• Proteases involved in erythrocyte invasion by the malaria parasite: function and potential as chemotherapeutic targets.

  2000cited by this paper
• Proteasomes and other self-compartmentalizing proteases in prokaryotes.

  1999cited by this paper
• Inhibition of Plasmodium falciparum Protein Synthesis

  1997cited by this paper
• Synchronization of Plasmodium falciparum erythrocytic stages in culture.

  1979cited by this paper
• Human malaria parasites in continuous culture.

  1976cited by this paper

• Structural and mechanistic insights into caseinolytic protease inhibition for antimicrobial development against Pseudomonas plecoglossicida

  2026cites this paper
• Allosteric regulation of proteolytic machines unveiled by the synergy between cryo-EM and solution NMR spectroscopy

  2025cites this paper
• Applying natural product repurposing strategy to identify baicalein as novel caseinolytic protease P inhibitor and its application in the treatment of rice bacterial diseases.

  2025cites this paper
• A dynamin-like protein in Plasmodium falciparum plays an essential role in parasite growth, mitochondrial development and homeostasis during asexual blood stages.

  2025cites this paper
• [Protein degradation in bacteria: focus on the ClpP protease].

  2024cites this paper
• Non-fused Pyrimidine Derivatives as Potential Pharmacological Entities: A Review.

  2024cites this paper
• A comprehensive review on human disease—causing bacterial proteases and their impeding agents

  2023cites this paper
• Intermolecular Hydrazinative Halogenation of Alkenes with Potassium Halides as Nucleophilic Halogen Sources: Modular Entry to Phenelzine Derivatives.

  2023cites this paper
• AMINATION OF 2-(2-OXO-2-ARYLETHYLTHIO)-PYRIMIDIN-4(3H)-ONE DERIVATIVES USING THE SULFONATE METHOD

  2023cites this paper
• The structure of caseinolytic protease subunit ClpP2 reveals a functional model of the caseinolytic protease system from Chlamydia trachomatis

  2022cites this paper
• Title: A Comprehensive Review on Classifying Fast-acting and Slow-acting Antimalarial Agents Based on Time of Action and Target Organelle of Plasmodium sp.

  2022cites this paper
• Discovery of a Novel Antimicrobial Agent by the Virtual Screening of a Library of Small Molecules

  2021cites this paper
• New Drug Discovery and Development in India to Counter Malaria

  2021cites this paper
• Development of Antibiotics That Dysregulate the Neisserial ClpP Protease.

  2020cites this paper
• Bicyclic 6-6 Systems With One Bridgehead Nitrogen Atom: Two Extra Heteroatoms 1:1

  2020cites this paper
• The in Vitro Antiplasmodial and Antiproliferative Activity of New Ferrocene‐Based α‐Aminocresols Targeting Hemozoin Inhibition and DNA Interaction

  2020cites this paper
• Discovery of novel peptidomimetic boronate ClpP inhibitors with noncanonical enzyme mechanism as potent virulence blockers in vitro and in vivo.

  2020cites this paper
• The Plasmodium falciparum proteasome as a drug target

  2020cites this paper
• Road Towards Development of New Antimalarial: Organelle Associated Metabolic Pathways in Plasmodium as Drug Targets and Discovery of Lead Drug Candidates

  2019cites this paper
• Repurposing a polymer precursor: Synthesis and in vitro medicinal potential of ferrocenyl 1,3-benzoxazine derivatives.

  2019cites this paper
• Inhibiting Mycobacterium tuberculosis ClpP1P2 by addressing the equatorial handle domain of ClpP1 subunit

  2019cites this paper
• ClpP Protease, a Promising Antimicrobial Target

  2019influential citation
• α-Amino Diphenyl Phosphonates as Novel Inhibitors of Escherichia coli ClpP Protease.

  2019cites this paper
• ClpP protease activation results from the reorganization of the electrostatic interaction networks at the entrance pores

  2019cites this paper
• Reversible inhibition of the ClpP protease via an N-terminal conformational switch

  2018cites this paper
• The proteasome as a target to combat malaria: hits and misses.

  2018cites this paper
• The Role of ClpP Protease in Bacterial Pathogenesis and Human Diseases.

  2018cites this paper
• Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.

  2017cites this paper